According to a market report by Lucintel, the future of the global OTC drug & dietary supplement market looks promising with opportunities in the tablets, hard capsules, powders, ointments, soft capsules, and liquids markets. The global OTC drug & dietary supplement market is expected to reach an estimated $256.13 billion by 2030 from $190. billion in 2024 at a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing awareness concerning general health issues and rising demand for personalized medicine for treating minor ailments.
A more than 150 – page report is developed to understand Trends, opportunity and forecast in OTC drug & dietary supplement market to 2030 by dosage form (tablets, hard capsules, powders, ointments, soft capsules, liquids, and others), distribution channel (pharmacies, grocery stores, vitamin & health food stores, online pharmacy, and others), product (branded drugs and generic drugs), category (vitamin & dietary supplements, cough & cold products, analgesics, gastrointestinal products, sleep aids, otic products, wart removers, mouth care products, ophthalmic products, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that generic drugs is expected to witness the higher growth over the forecast period.
Within this market, tablets will remain the largest segment.
Download sample by clicking on OTC drug & dietary supplement market
North America is expected to witness highest growth over the forecast period.
Johnson & Johnson, copyright, Sanofi, Roche, Astrazeneca, Glaxosmithkline, Novartis, Merck & Co., Bayer Healthcare, and Gilead Sciences are the major suppliers in the OTC drug & dietary supplement market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]To get access of more than 1000 reports at fraction of cast visit Lucintel’sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1 972.636.5056
Explore Our Latest Publications
Global Composite Cylinder Market
Comments on “Lucintel Forecasts the Global OTC Drug & Dietary Supplement Market to Reach $256.13 billion by 2030”